Sage Journals: Discover world-class research

Retricted access

Research article

First published 2016-08

Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2,3-Dioxygenase

Rajni Sharma, Giulia Di Dalmazi, Patrizio Caturegli

Thyroid®

Retricted access

Research article

First published 2021-12

Distinct Cytokine Signatures in Thyroiditis Induced by PD-1 or CTLA-4 Blockade: Insights from a New Mouse Model

Silvia Ippolito, Giulia Di Dalmazi, Fabiana Pani [...]

Thyroid®

Open access

Review article

First published 2023

The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition

Firas Y. Kreidieh, Hussein A. Tawbi

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2022-02

Increased Risk of Thyroid Dysfunction with Combination PD-1 and CTLA-4 Blockade,Even in the Absence of Positive Thyroid Antibodies

Anupam Kotwal

Clinical Thyroidology®

Open access

Research article

First published 2024

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)

Young Kwang Chae, Megan Othus, Sandip Pravin Patel [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2003-12

CTLA-4 AT-Repeat Polymorphism Reduces the Inhibitory Function of CTLA-4 in Graves' Disease

Masaki Takara, Tsuyoshi Kouki, Leslie J. DeGroot

Thyroid®

Open access

Research article

First published 2024

Second-line treatment of PD-1 and CTLA-4 blockade combined with liposomal irinotecan plus leucovorin and fluorouracil for advanced cholangiocarcinoma: study protocol of a single-arm,prospective phase II trial

Heqi Yang, Linjuan Li, Xiaofen Li [...]

Therapeutic Advances in Medical Oncology

Open access

Correction

First published 2025

Corrigendum to “Second-line treatment of PD-1 and CTLA-4 blockade combined with liposomal irinotecan plus leucovorin and fluorouracil for advanced cholangiocarcinoma: study protocol of a single-arm,prospective phase II trial”

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2017-1

Immune Checkpoint Inhibitors in the Cancer Patient with An Organ Transplant

Rimda Wanchoo, Leonardo V. Riella, Nupur N. Uppal [...]

Journal of Onco-Nephrology

Retricted access

Research article

First published 2010-03

HIV-Specific TGF- β -Positive CD4 + T Cells Do Not Express Regulatory Surface Markers and Are Regulated by CTLA-4

Mohamed Elrefaei, Candace M. Burke, Chris A.R. Baker [...]

AIDS Research and Human Retroviruses

Search results